Stay updated on Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial page.

Latest updates to the Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe page history now shows a new revision label (v3.6.4) replacing the previous v3.6.3, indicating a software/system update to the page.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe revision history now shows the latest published revision as v3.6.3, replacing the previous v3.6.2, indicating a minor update to the page's published revision.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page history shows a newer revision entry (v3.6.2) replacing the previous v3.6.0, indicating a minor update to the page's revision record.SummaryDifference0.1%

- Check53 days agoChange DetectedThe record history now includes a recruitment status update indicating no further participant enrollment, and a new revision entry (v3.6.0) alongside the removal of a previous revision (v3.5.5).SummaryDifference0.2%

- Check60 days agoChange DetectedA new Revision: v3.5.5 entry was added to the history and the previous Revision: v3.5.4 was removed, updating the page's version history.SummaryDifference0.1%

- Check74 days agoChange DetectedThe study record gains updated Study Status and Contacts/Locations sections. These changes reflect the current status and contact details for the trial.SummaryDifference0.3%

Stay in the know with updates to Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lorigerlimab with Docetaxel in Prostate Cancer Clinical Trial page.